The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125276792 12527679 2 F 20160606 20160628 20160705 20160706 EXP PHHY2016FR090751 SANDOZ 27.81 YR M Y 0.00000 20160706 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125276792 12527679 1 SS ZOPHREN ONDANSETRON 1 Intravenous (not otherwise specified) 8 MG, QD U 0 8 MG SOLUTION FOR INJECTION QD
125276792 12527679 2 PS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 150 MG, PER COURSE U 200146 150 MG
125276792 12527679 3 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 150 MG, PER COURSE U 200146 150 MG
125276792 12527679 4 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 150 MG, PER COURSE U 200146 150 MG
125276792 12527679 5 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 150 MG, PER COURSE U 200146 150 MG
125276792 12527679 6 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 150 MG, PER COURSE U 200146 150 MG
125276792 12527679 7 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 150 MG, PER COURSE U 200146 150 MG
125276792 12527679 8 SS IFOSFAMIDE. IFOSFAMIDE 1 Intravenous (not otherwise specified) 10000 MG, PER COURSE U EG: 5J271M5 0 10000 MG
125276792 12527679 9 SS IFOSFAMIDE. IFOSFAMIDE 1 Intravenous (not otherwise specified) 10000 MG, PER COURSE U EG: 5J271M5 0 100001 MG
125276792 12527679 10 SS IFOSFAMIDE. IFOSFAMIDE 1 Intravenous (not otherwise specified) 10000 MG, PER COURSE U EG: 5J271M5 0 10000 MG
125276792 12527679 11 SS IFOSFAMIDE. IFOSFAMIDE 1 Intravenous (not otherwise specified) 10000 MG, PER COURSE U EG: 5J271M5 0 10000 MG
125276792 12527679 12 SS IFOSFAMIDE. IFOSFAMIDE 1 Intravenous (not otherwise specified) 10000 MG, PER COURSE U EG: 5J271M5 0 10000 MG
125276792 12527679 13 SS IFOSFAMIDE. IFOSFAMIDE 1 Intravenous (not otherwise specified) 10000 MG, PER COURSE U EG: 5J271M5 0 10000 MG
125276792 12527679 14 SS MESNA. MESNA 1 Intravenous (not otherwise specified) 500 MG/M2 PER COURSE U 0 500 MG/M**2
125276792 12527679 15 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 80 MG, UNK U 0 80 MG
125276792 12527679 16 C EMEND APREPITANT 1 Oral 80 MG, UNK U 0 80 MG
125276792 12527679 17 C PREZISTA DARUNAVIR ETHANOLATE 1 Unknown U 0
125276792 12527679 18 C ISENTRESS RALTEGRAVIR POTASSIUM 1 Oral 2 DF, QD U 0 2 DF FILM-COATED TABLET QD
125276792 12527679 19 C TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 200 MG, QD U 0 200 MG QD
125276792 12527679 20 C LYRICA PREGABALIN 1 Oral 200 MG, BID U 0 200 MG BID
125276792 12527679 21 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 1 DF, QW3 U 0 1 DF TABLET TIW
125276792 12527679 22 C NORVIR RITONAVIR 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125276792 12527679 1 Prophylaxis of nausea and vomiting
125276792 12527679 2 Sarcoma
125276792 12527679 8 Sarcoma
125276792 12527679 14 Prophylaxis
125276792 12527679 15 Prophylaxis of nausea and vomiting
125276792 12527679 16 Prophylaxis of nausea and vomiting
125276792 12527679 17 Product used for unknown indication
125276792 12527679 18 Acquired immunodeficiency syndrome
125276792 12527679 19 Acquired immunodeficiency syndrome
125276792 12527679 20 Pain
125276792 12527679 21 Prophylaxis
125276792 12527679 22 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125276792 12527679 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125276792 12527679 Somnolence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125276792 12527679 1 20160222 0
125276792 12527679 2 20160222 0
125276792 12527679 3 20160314 0
125276792 12527679 4 20160404 0
125276792 12527679 5 20160425 0
125276792 12527679 6 20160517 0
125276792 12527679 7 20160606 0
125276792 12527679 8 20160222 0
125276792 12527679 9 20160314 0
125276792 12527679 10 20160404 0
125276792 12527679 11 20160425 0
125276792 12527679 12 20160517 0
125276792 12527679 13 20160606 0
125276792 12527679 15 20160222 0
125276792 12527679 16 20160222 0
125276792 12527679 18 20160225 0
125276792 12527679 19 20160225 0
125276792 12527679 20 201601 0
125276792 12527679 21 20160225 0